|
|
| Catalog Number |
1010002 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hernia (2240)
|
| Date of Event |
11/05/2018
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported through a legal event that a 59 male patient had hernia repair surgery on or about (b)(6) 2018.During the hernia repair surgery, the surgeon implanted a strattice mesh; lot no.Sp100559.Following the initial implant of the mesh device, and due to complications concerning same, the patient was required to undergo revision surgeries, including additional mesh implantation as follows: on or about (b)(6) 2018, when the patient was implanted with:lifecell strattice mesh, lot no.Sp100622-095; (b)(6) 2018; (b)(6) 2019.When the patient was implanted with lifecell strattice mesh, lot no.: sp20009066; and (b)(6) 2020, when the patient was implanted with lifecell strattice mesh, lot no: sp20022023.This record is associated with the device implanted on august 20, 2018; lot sp100622-095.It was also reported the patient was implanted with device lot no: sp20022023 on (b)(6) 2020.However ,there is no event reported after the implantation and therefore an additional complaint record will not be opened for sp20022023.It should also be noted this in an invalid lot number.This is the same event and the same patient reported under mdr # 1000306051-2023-00100 abbvie complaint # (b)(4), and, mdr # 1000306051-2023-00101.Abbvie complaint # (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
This legal event is being reported as serious injury due to the reported recurrence with surgical intervention.Internal investigation into strattice lot sp100622, included a review of the reported information, review of the device history records, and a review of the complaint history records.The investigation resulted in no remarkable findings, including no other complaints reported against the lot and no deviations or related non-conformances revealed during processing.The lot was terminally sterilized within the process parameters and met all qc release criteria.As of (b)(6) 2023, of the 114 devices released to finished goods for lot sp100622, 110 have been distributed with 66 reported as implanted.Based on our internal investigation with no remarkable findings, and without relevant patient factors, a relationship between the strattice and this event could not be determined.Due to the legal process, if additional information is made available during legal proceedings.A supplemental report will be submitted.
|
| |
|
Search Alerts/Recalls
|
|
|